arrow
H

Hai-Bin Shi

Nanjing Medical University
H指数:32
被引数:4,060

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-Line Thrombectomy for Acute Intracranial Atherosclerotic Stenosis-Related Vertebrobasilar Artery Occlusion: Stent Retriever-Based Versus Contact Aspiration Thrombectomy Strategies

急性颅内动脉粥样硬化性狭窄相关椎基底动脉闭塞的一线血栓切除:支架取栓与接触性抽吸血栓切除策略的比较

2026-10-080
PRE
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)

卡瑞利珠单抗和安罗替尼联合或不联合经动脉化疗栓塞作为晚期肝细胞癌的一线治疗(CHANCE2311)

2026-03-310
PRE
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)

在联合免疫治疗和靶向治疗后,纵向身体组成可识别恶病质的肝细胞癌 (CHANCE2213)

2024-11-270
OA
Transarterial chemoembolization combined with molecular targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma beyond the up-to-seven criteria: a propensity score-matching analysis

经动脉化疗栓塞联合分子靶向药物加免疫检查点抑制剂治疗超过7个标准的不可切除肝细胞癌: 倾向评分匹配分析

2024-11-010
OAAI